Glycerol Phenylbutyrate oral
Glycerol Phenylbutyrate oral is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Glycerol Phenylbutyrate. Available dosage form: liquid.
Drug details
- Generic Name
- Glycerol Phenylbutyrate oral
- Brand Names
- Glycerol Phenylbutyrate
- Application Number
- ANDA205742
- Sponsor
- Camber Pharmaceuticals, Inc.
- NDC Codes
- 2
- Dosage Forms
- LIQUID
- Routes
- ORAL
- Active Ingredients
- GLYCEROL PHENYLBUTYRATE
Indications and Usage
1 INDICATIONS AND USAGE Glycerol phenylbutyrate oral liquid is indicated for use as a nitrogen-binding agent for chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. Glycerol phenylbutyrate oral liquid must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements). Limitations of Use : • Glycerol phenylbutyrate oral liquid is not indicated for the treatment of acute hyperammonemia in patients with UCDs because more rapidly acting interventions are essential to reduce plasma ammonia levels. • The safety and efficacy of glycerol phenylbutyrate oral liquid for the treatment of N -acetylglutamate synthase (NAGS) deficiency has not been established. Glycerol phenylbutyrate is a nitrogen-binding agent indicated for chronic management of patients with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. Glycerol phenylbutyrate oral liquid must be used with dietary protein restriction and, in some cases, dietary supplements. ( 1 ) Limitations of Use: • Glycerol phenylbutyrate oral liquid is not indicated for treatment of acute hyperammonemia in patients with UCDs. ( 1 ) • Safety and efficacy for treatment of N-acetylglutamate synthase (NAGS) deficiency has not been established. ( 1 )